
Date
Event

1
Apr
Deloitte | Path to Public Series – Life Science IPO exit strategies: Planning to execution
Tuesday, Apr 1, 202510:00—11:00am
A virtual discussion presented by Deloitte’s Capital Markets Transactions practice.
Deloitte Life Sciences IPO Co-leaders Tasia Blazevich and B.J. Spence, along with Carlos Ramirez, Cooley Partner, will lead a discussion on key considerations and strategies, featuring industry leaders sharing perspectives on navigating the IPO process.
Industry-leading professionals and experienced executives will address topics such as:
- Capital markets update
- IPO strategy overview
- Perspectives from industry-leading advisors
- Reflections from C-Suite executives on lessons learned
9:00AM – 10:00AM PDT
10:00AM – 11:00AM MDT